We are live on
!
Find out more
PCA
Personal Capital Advisors Portfolio holdings
AUM
$20.6B
1-Year Est. Return
13.65%
This Fund
S&P 500
This Quarter
Est. Return
-6.2%
1 Year Est. Return
-13.65%
3 Year Est. Return
+17.55%
5 Year Est. Return
+33.04%
10 Year Est. Return
–
AUM
$18.5B
AUM Growth
-$589M
(-3.1%)
Cap. Flow
+$804M
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
42.74%
Holding
476
New
33
Increased
302
Reduced
83
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$132M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$54.8M |
| 3 |
Edwards Lifesciences
EW
|
+$51.6M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$51.3M |
| 5 |
Fortinet
FTNT
|
+$51.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$147M |
| 2 |
Encompass Health
EHC
|
+$43.8M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$28.2M |
| 4 |
Under Armour Class C
UA
|
+$22.1M |
| 5 |
UnitedHealth
UNH
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.15% |
| 2 | Consumer Staples | 4.49% |
| 3 | Utilities | 4.26% |
| 4 | Healthcare | 3.85% |
| 5 | Financials | 3.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Applied Materials
AMAT
$403B
| $550K | ﹤0.01% |
6,715
+23
| +0.3% | +$2.22K |
|
277
McKesson
MCK
$100B
| $548K | ﹤0.01% |
+1,613
| New | +$560K |
|
278
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $544K | ﹤0.01% |
4,464
-1,425
| -24% | -$193K |
|
|
MRSH
279
Marsh
MRSH
$90.5B
| $537K | ﹤0.01% |
3,595
-23
| -0.6% | -$3.69K |
|
280
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$770M
| $533K | ﹤0.01% |
17,799
| – | – |
|
|
281
Encompass Health
EHC
$11B
| $529K | ﹤0.01% |
11,688
-876,022
| -99% | -$43.8M |
|
282
Zscaler
ZS
$24.5B
| $526K | ﹤0.01% |
3,200
-1,024
| -24% | -$168K |
|
283
Emerson Electric
EMR
$83.9B
| $512K | ﹤0.01% |
6,998
+305
| +5% | +$25.3K |
|
284
Airbnb
ABNB
$89.9B
| $505K | ﹤0.01% |
4,812
+643
| +15% | +$71.3K |
|
285
Gilead Sciences
GILD
$162B
| $498K | ﹤0.01% |
8,066
+16
| +0.2% | +$1.01K |
|
286
Trimble
TRMB
$13.2B
| $495K | ﹤0.01% |
9,124
| – | – |
|
287
Morgan Stanley
MS
$331B
| $493K | ﹤0.01% |
6,239
+444
| +8% | +$37.4K |
|
288
Shell
SHEL
$254B
| $493K | ﹤0.01% |
9,906
+4,932
| +99% | +$254K |
|
289
Cigna
CI
$73.7B
| $477K | ﹤0.01% |
1,720
+761
| +79% | +$214K |
|
290
Altria Group
MO
$114B
| $477K | ﹤0.01% |
11,812
+505
| +4% | +$22K |
|
291
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.1B
| $475K | ﹤0.01% |
1,652
+410
| +33% | +$130K |
|
292
W.P. Carey
WPC
$16.8B
| $469K | ﹤0.01% |
6,866
+2,646
| +63% | +$217K |
|
293
AstraZeneca
AZN
$263B
| $466K | ﹤0.01% |
4,252
+496
| +13% | +$62.9K |
|
294
RPM International
RPM
$13.7B
| $465K | ﹤0.01% |
5,578
| – | – |
|
295
SI-BONE Inc
SIBN
$788M
| $465K | ﹤0.01% |
26,630
| – | – |
|
296
Helios Technologies
HLIO
$2.57B
| $463K | ﹤0.01% |
9,150
-449
| -5% | -$27.1K |
|
297
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $460K | ﹤0.01% |
7,296
+820
| +13% | +$56.6K |
|
|
FBC
298
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $459K | ﹤0.01% |
13,750
+2,314
| +20% | +$88.4K |
|
299
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
| $456K | ﹤0.01% |
10,307
+1,988
| +24% | +$96.7K |
|
300
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $450K | ﹤0.01% |
9,215
+698
| +8% | +$38.3K |
|
Similar funds
PG
RCAMU
GG
AIM
AAM
ZCA
GJIC
SBL
Personal Capital Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Personal Capital Advisors held 476 positions worth $18.5B, down 3.1% from $19.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Personal Capital Advisors deployed $804M of net new capital in Q3 2022, opening 33 new positions and adding to 302 existing holdings. Its largest new stake was Edwards Lifesciences: 536,233 shares worth $44.3M.
By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.8% a quarter earlier, followed by Consumer Staples and Utilities.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $147M trimmed.
- Personal Capital Advisors's largest Q3 2022 buy was Edwards Lifesciences: 536,233 shares worth $44.3M.
- Personal Capital Advisors added most to Schwab International Equity ETF in Q3 2022, an estimated $132M increase.
- Personal Capital Advisors's biggest Q3 2022 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $147M.
- Personal Capital Advisors fully exited InterDigital in Q3 2022, selling an estimated $11.1M.
- Personal Capital Advisors's ten largest holdings make up 43% of its $18.5B portfolio in Q3 2022.
- Personal Capital Advisors opened 33 new positions and closed 23 in Q3 2022.
- Personal Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $18.5B.
Based on Personal Capital Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.